{"text": ["Biotech", "Stock", "On", "The", "Radar:", "FDA", "Verdict", "Ahead", "For", "Pfenex's", "Osteoporosis", "Biosimilar"], "created_at": "2019-10-03 19:49:50"}
{"text": ["Top", "Research", "Reports", "for", "Bank", "of", "America,", "Home", "Depot", "&", "Philip", "Morris"], "created_at": "2019-10-03 17:23:05"}
{"text": ["Pres.", "Trump", "to", "expand", "private", "Medicare", "Advantage", "program"], "created_at": "2019-10-03 16:32:13"}
{"text": ["Why", "Lilly", "(LLY)", "Could", "Beat", "Earnings", "Estimates", "Again"], "created_at": "2019-10-03 14:10:02"}
{"text": ["Novartis", "Reports", "Additional", "Data", "on", "Spondylitis", "Drug", "Cosentyx"], "created_at": "2019-10-03 14:09:02"}
{"text": ["Eli", "Lilly", "to", "voluntarily", "delist", "from", "Euronext", "Paris", "exchange"], "created_at": "2019-10-03 13:37:00"}
{"text": ["Here's", "Why", "You", "Should", "Add", "Thermo", "Fisher", "to", "Your", "Portfolio"], "created_at": "2019-10-03 13:30:01"}
{"text": ["Lilly", "Announces", "Voluntary", "Delisting", "from", "Euronext", "Paris"], "created_at": "2019-10-03 13:25:00"}
{"text": ["New", "Head-to-Head", "Data", "Show", "Taltz\u00ae", "(ixekizumab)", "Superiority", "versus", "TREMFYA\u00ae", "(guselkumab)", "in", "People", "with", "Moderate", "to", "Severe", "Plaque", "Psoriasis"], "created_at": "2019-10-03 10:45:00"}
